Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Generating longitudinal screening algorithms using novel biomarkers for disease.

Martin W McIntosh1, Nicole Urban, Beth Karlan

  • 1Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. mmcintos@fhcrc.org

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
|February 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

O-linked glycan-dependent gating of TPC2 controls lysosomal excitability and organelle remodeling.

Nature communications·2026
Same author

Real-world genetic testing data of ovarian cancer patients: Informing counseling and risk reduction in patients over age seventy.

Gynecologic oncology·2026
Same author

Oncofertility patterns after the overturn of Roe v. Wade.

Journal of the National Cancer Institute·2026
Same author

Ideal efficacy photoswitching for chromocontrol of TRPC4/5 channel functions in live tissues.

Nature chemical biology·2026
Same author

Activation of TRPV3 channels in bladder cancer cells stimulates ATP release.

Molecular pharmacology·2025
Same author

Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2.

Journal of the National Cancer Institute·2025
Same journal

Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Retraction: Menstrual Factors, Reproductive History and Liver Cancer Risk: Findings from a Prospective Cohort Study in Chinese Women.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Optimizing the Uptake and Completion of the Cervical Cancer Screening Continuum: Opportunity Knocks, Including at Home.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Sex Differences in Cancer Stage at Diagnosis of Nonreproductive Solid Organ Tumors in the United States, 2015 to 2022.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Evaluation of the 4Kscore in EPIC: Reply.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Evaluation of the 4Kscore in EPIC: Letter.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
See all related articles

A new screening algorithm uses statistical modeling to create personalized cancer detection thresholds for novel biomarkers. This approach improves early diagnosis accuracy by adapting to individual patient data and various tumor behaviors.

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Statistical Modeling

Background:

  • Molecular technology advances enable new tumor biomarker discovery for cancer screening.
  • Current screening algorithms often rely on assumptions unsuitable for novel markers.
  • Practical screening requires high sensitivity with controlled specificity to prevent false positives.

Purpose of the Study:

  • Develop a robust algorithm for early cancer detection using novel biomarkers.
  • Address limitations of existing algorithms regarding data availability and marker behavior.
  • Create a personalized screening approach adaptable to diverse tumor growth patterns.

Main Methods:

  • Utilized Parametric Empirical Bayes statistical theory to model marker trajectories in healthy subjects.

Related Experiment Videos

  • Developed person-specific thresholds based on individual screening history and a specified false-positive rate.
  • Designed an algorithm robust to various tumor growth behaviors and preclinical marker uncertainties.

    • Main Results:

    • The proposed algorithm provides simple, graph-representable person-specific screening thresholds.
    • It demonstrates robustness in detecting a wide range of tumor behaviors.
    • Statistical analysis for algorithm generation is compatible with standard statistical packages.

    Conclusions:

    • The Parametric Empirical Bayes screening algorithm is crucial for evaluating novel marker discoveries.
    • It offers a reliable method for early cancer detection, especially with new, uncharacterized markers.
    • This personalized approach enhances screening utility by accommodating individual patient data and marker variability.